Budget deal costs pharma

President Donald Trump signed a bipartisan budget agreement on Friday that imposes new costs on drug companies.

The deal includes new rules that shift billions of dollars in costs to pharmaceutical companies from Medicare Part D plans by increasing the discounts companies are required to pay for patients whose drug costs fall in the "donut hole" coverage gap. ...